These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 26882566

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-Girdin signaling pathway.
    Wang Y, Yuan L, Yang XM, Wei D, Wang B, Sun XX, Feng F, Nan G, Wang Y, Chen ZN, Bian H.
    Clin Exp Metastasis; 2015 Jan; 32(1):39-53. PubMed ID: 25424030
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway.
    Chen K, Zhang S, Ji Y, Li J, An P, Ren H, Liang R, Yang J, Li Z.
    PLoS One; 2013 Jan; 8(9):e72927. PubMed ID: 24039823
    [Abstract] [Full Text] [Related]

  • 7. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
    Hsieh SC, Tsai JP, Yang SF, Tang MJ, Hsieh YH.
    Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054
    [Abstract] [Full Text] [Related]

  • 8. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
    Li WX, Chen LP, Sun MY, Li JT, Liu HZ, Zhu W.
    Oncotarget; 2015 Sep 15; 6(27):23776-92. PubMed ID: 26068982
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. I131 reinforces antitumor activity of metuximab by reversing epithelial-mesenchymal transition via VEGFR-2 signaling in hepatocellular carcinoma.
    Wu L, Sun B, Lin X, Liu C, Qian H, Chen L, Yang Y, Shen F, Su C.
    Genes Cells; 2018 Jan 15; 23(1):35-45. PubMed ID: 29210217
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of CD147 expression alters cytoskeleton architecture and inhibits gelatinase production and SAPK pathway in human hepatocellular carcinoma cells.
    Qian AR, Zhang W, Cao JP, Yang PF, Gao X, Wang Z, Xu HY, Weng YY, Shang P.
    J Exp Clin Cancer Res; 2008 Oct 11; 27(1):50. PubMed ID: 18847500
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling.
    Tan ZB, Fan HJ, Wu YT, Xie LP, Bi YM, Xu HL, Chen HM, Li J, Liu B, Zhou YC.
    J Ethnopharmacol; 2019 Mar 25; 232():62-72. PubMed ID: 30553869
    [Abstract] [Full Text] [Related]

  • 20. BetaIg-h3 is involved in the HAb18G/CD147-mediated metastasis process in human hepatoma cells.
    Tang J, Zhou HW, Jiang JL, Yang XM, Li Y, Zhang HX, Chen ZN, Guo WP.
    Exp Biol Med (Maywood); 2007 Mar 25; 232(3):344-52. PubMed ID: 17327467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.